CWG
BSX icon

Crown Wealth Group’s Boston Scientific BSX Stock Holding History

Crown Wealth Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,135
Closed -$204K – 148
2025
Q4 		$204K Sell
2,135
-103
-5% -$10.1K 0.06% 138
2025
Q3 		$218K Buy
2,238
+100
+5% +$10.4K 0.07% 113
2025
Q2 		$230K Buy
2,138
+12
+0.6% +$1.21K 0.09% 102
2025
Q1 		$214K Buy
+2,126
New +$214K 0.11% 101
2024
Q4 		– Sell
-2,825
Closed -$237K – 114
2024
Q3 		$237K Buy
+2,825
New +$223K 0.1% 97

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Crown Wealth Group's BSX Position: Q1 2026 in Review

Crown Wealth Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,135 shares — an estimated $204K sold.

Crown Wealth Group first reported a position in BSX in Q3 2024 and held it in 5 quarters. The position peaked at $237K in Q3 2024. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Crown Wealth Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Crown Wealth Group sold 2,135 Boston Scientific shares in Q1 2026, an estimated $204K.
  • Crown Wealth Group first reported a position in Boston Scientific in Q3 2024 and held it in 5 quarters.
  • Crown Wealth Group's Boston Scientific position peaked at $237K in Q3 2024.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Crown Wealth Group's 13F filing for Q1 2026, filed 21 Apr 2026.